183 related articles for article (PubMed ID: 34400070)
21. Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes.
Westerman ME; Parker WP; Viers BR; Rivera ME; Karnes RJ; Frank I; Tarrell R; Thapa P; Thompson RH; Tollefson MK; Boorjian SA
Urol Oncol; 2016 Nov; 34(11):485.e1-485.e6. PubMed ID: 27423823
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
Zehnder P; Studer UE; Daneshmand S; Birkhäuser FD; Skinner EC; Roth B; Miranda G; Burkhard FC; Cai J; Skinner DG; Thalmann GN; Gill IS
BJU Int; 2014 Apr; 113(4):554-60. PubMed ID: 24131453
[TBL] [Abstract][Full Text] [Related]
23. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
[TBL] [Abstract][Full Text] [Related]
24. Comparative effectiveness of robot-assisted vs. open radical cystectomy.
Hanna N; Leow JJ; Sun M; Friedlander DF; Seisen T; Abdollah F; Lipsitz SR; Menon M; Kibel AS; Bellmunt J; Choueiri TK; Trinh QD
Urol Oncol; 2018 Mar; 36(3):88.e1-88.e9. PubMed ID: 29277584
[TBL] [Abstract][Full Text] [Related]
25. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
[TBL] [Abstract][Full Text] [Related]
26. Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Raza SJ; Wilson T; Peabody JO; Wiklund P; Scherr DS; Al-Daghmin A; Dibaj S; Khan MS; Dasgupta P; Mottrie A; Menon M; Yuh B; Richstone L; Saar M; Stoeckle M; Hosseini A; Kaouk J; Mohler JL; Rha KH; Wilding G; Guru KA
Eur Urol; 2015 Oct; 68(4):721-8. PubMed ID: 25985883
[TBL] [Abstract][Full Text] [Related]
27. Restrictive transfusion in radical cystectomy is safe.
Syan-Bhanvadia S; Drangsholt S; Shah S; Cai J; Miranda G; Djaladat H; Daneshmand S
Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526
[TBL] [Abstract][Full Text] [Related]
28. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
[TBL] [Abstract][Full Text] [Related]
29. Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy.
Milenkovic U; Akand M; Moris L; Demaegd L; Muilwijk T; Bekhuis Y; Laenen A; Van Cleynenbreugel B; Everaerts W; Van Poppel H; Dumez H; Albersen M; Joniau S
World J Urol; 2019 Sep; 37(9):1857-1866. PubMed ID: 30519746
[TBL] [Abstract][Full Text] [Related]
30. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
31. Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk.
McFerrin C; Raza SJ; May A; Davaro F; Siddiqui S; Hamilton Z
Int Urol Nephrol; 2019 Oct; 51(10):1755-1762. PubMed ID: 31346955
[TBL] [Abstract][Full Text] [Related]
32. The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.
Mayr R; May M; Burger M; Martini T; Pycha A; Dechet C; Lodde M; Comploj E; Wieland WF; Denzinger S; Otto W; Aziz A; Fritsche HM; Gierth M
Urol Int; 2014; 93(3):303-10. PubMed ID: 25139069
[TBL] [Abstract][Full Text] [Related]
33. Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
Diamantopoulos LN; Sekar RR; Holt SK; Khaki AR; Miller NJ; Gadzinski A; Nyame YA; Vakar-Lopez F; Tretiakova MS; Psutka SP; Gore JL; Lin DW; Schade GR; Hsieh AC; Lee JK; Yezefski T; Schweizer MT; Cheng HH; Yu EY; True LD; Montgomery RB; Grivas P; Wright JL
Urol Oncol; 2021 Aug; 39(8):496.e1-496.e8. PubMed ID: 33551249
[TBL] [Abstract][Full Text] [Related]
34. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
35. Postoperative Outcomes After Radical Cystectomy in Patients With Prior Pelvic Radiation.
Fontenot PA; Barnes BD; Parker WP; Wyre H; Lee EK; Holzbeierlein JM
Urology; 2018 Jun; 116():131-136. PubMed ID: 29545052
[TBL] [Abstract][Full Text] [Related]
36. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
[TBL] [Abstract][Full Text] [Related]
37. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder.
Stensland KD; Zaid H; Broadwin M; Sorcini A; Canes D; Galsky M; Moinzadeh A
Eur Urol Oncol; 2020 Aug; 3(4):509-514. PubMed ID: 31411987
[TBL] [Abstract][Full Text] [Related]
38. Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study.
Mao S; Wu Y; Wang R; Guo Y; Yuan J; Zhang W; Zhang J; Yan Y; Yao X
Investig Clin Urol; 2020 Jul; 61(4):382-389. PubMed ID: 32665994
[TBL] [Abstract][Full Text] [Related]
39. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
Gakis G; Ngamsri T; Rausch S; Mischinger J; Todenhöfer T; Schwentner C; Schmid MA; Hassan FA; Renninger M; Stenzl A
World J Urol; 2015 Oct; 33(10):1429-37. PubMed ID: 25595732
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Soave A; John LM; Dahlem R; Minner S; Engel O; Schmidt S; Kluth LA; Fisch M; Rink M
Urology; 2015 Jul; 86(1):92-8. PubMed ID: 26051839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
